CerebNet: A fast and reliable deep-learning pipeline for detailed cerebellum sub-segmentation.

Journal: NeuroImage
Published Date:

Abstract

Quantifying the volume of the cerebellum and its lobes is of profound interest in various neurodegenerative and acquired diseases. Especially for the most common spinocerebellar ataxias (SCA), for which the first antisense oligonculeotide-base gene silencing trial has recently started, there is an urgent need for quantitative, sensitive imaging markers at pre-symptomatic stages for stratification and treatment assessment. This work introduces CerebNet, a fully automated, extensively validated, deep learning method for the lobular segmentation of the cerebellum, including the separation of gray and white matter. For training, validation, and testing, T1-weighted images from 30 participants were manually annotated into cerebellar lobules and vermal sub-segments, as well as cerebellar white matter. CerebNet combines FastSurferCNN, a UNet-based 2.5D segmentation network, with extensive data augmentation, e.g. realistic non-linear deformations to increase the anatomical variety, eliminating additional preprocessing steps, such as spatial normalization or bias field correction. CerebNet demonstrates a high accuracy (on average 0.87 Dice and 1.742mm Robust Hausdorff Distance across all structures) outperforming state-of-the-art approaches. Furthermore, it shows high test-retest reliability (average ICC >0.97 on OASIS and Kirby) as well as high sensitivity to disease effects, including the pre-ataxic stage of spinocerebellar ataxia type 3 (SCA3). CerebNet is compatible with FreeSurfer and FastSurfer and can analyze a 3D volume within seconds on a consumer GPU in an end-to-end fashion, thus providing an efficient and validated solution for assessing cerebellum sub-structure volumes. We make CerebNet available as source-code (https://github.com/Deep-MI/FastSurfer).

Authors

  • Jennifer Faber
    German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; Department of Neurology, University Hospital Bonn, Germany.
  • David Kügler
    DZNE Bonn, Bonn, Germany.
  • Emad Bahrami
    German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; Computer Science Department, University Bonn, Bonn, Germany.
  • Lea-Sophie Heinz
    German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Dagmar Timmann
    Department of Neurology, Essen University Hospital, University of Duisburg-Essen, Essen, Germany.
  • Thomas M Ernst
    Department of Neurology, Center for Translational Neuro, and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Katerina Deike-Hofmann
    Department of Neuroradiology, University Hospital Bonn, Germany.
  • Thomas Klockgether
    German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; Department of Neurology, University Hospital Bonn, Germany.
  • Bart van de Warrenburg
    Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud university medical center, Nijmegen, The Netherlands.
  • Judith van Gaalen
    Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud university medical center, Nijmegen, The Netherlands.
  • Kathrin Reetz
    Department of Neurology, RWTH Aachen University, Germany; JARA-Brain Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich, Germany.
  • Sandro Romanzetti
    Department of Neurology, RWTH Aachen University, Germany.
  • Gulin Oz
    Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA.
  • James M Joers
    Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA.
  • Jorn Diedrichsen
    Departments of Computer Science and Statistical and Actuarial Sciences, Western University, London, ON, Canada.
  • Martin Reuter
    Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA; German Centre for Neurodegenerative Diseases (DZNE), Department of Image Analysis, Bonn, Germany.